US News

Biontech announces development of adapted vaccine for Omicron variant

Published by
DPA

The German vaccine manufacturer Biontech has announced that it is developing an adapted vaccine as a “precautionary measure” while simultaneously carrying out research on the nature of the new Omicron variant of the coronavirus. “To avoid wasting time, we are tackling these two tasks in parallel until the data is available and we have more information on whether the vaccine needs to be adapted or not,” a Biontech spokeswoman told dpa on Monday. The two undertakings even partially coincide, according to Biontech. “We immediately began studies on the Omicron variant,” the company said. “We have …

Read More

Facebook Comments

Check Also

Austrian parliament votes on compulsory Covid vaccinations for adults

Published by DPA Austria’s parliament was debating on ...

Archives